SCHEMBL8909302

SCHEMBL8909302

CNC(=O)NCc1ccccc1-c1ccc(CN2C(=O)[C@H](NC(=O)CC(C)(C)N)CCc3cccnc32)cc1

nearest known ligand 0.68

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 4/20 0.68
AGTR1 P30556 1/20 0.55
XIAP P98170 8/20 0.42
RIPK1 Q13546 5/20 0.38
NPY1R P25929 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8908992 0.92 GHSR (0.80) GHSRAGTR1XIAPRIPK1NPY1R
SCHEMBL29958746 0.89 GHSR (0.84) GHSRAGTR1XIAPNPY1R
SCHEMBL7785968 0.89 GHSR (0.84) GHSRAGTR1XIAPNPY1R
SCHEMBL8909161 0.89 GHSR (0.58) GHSRAGTR1XIAPRIPK1
SCHEMBL8909668 0.89 GHSR (0.56) GHSRAGTR1XIAPRIPK1NPY1R
SCHEMBL8909305 0.88 GHSR (0.58) GHSRAGTR1XIAPRIPK1
SCHEMBL8909729 0.84 GHSR (0.56) GHSRAGTR1XIAPRIPK1
SCHEMBL8909721 0.84 GHSR (0.56) GHSRAGTR1XIAPRIPK1
SCHEMBL7791981 0.84 GHSR (0.71) GHSRAGTR1XIAPNPY1R
SCHEMBL7794454 0.83 GHSR (0.85) GHSRAGTR1XIAPNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5606054-A Heterocyclic-fused lactams promote release of growth hormone MERCK & CO., INC. (US) 1997-02-25 US claimed
WO-1995016692-A1 HETEROCYCLIC-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO., INC. (US) 1995-06-22 WO claimed
US-5606054-A Heterocyclic-fused lactams promote release of growth hormone MERCK & CO., INC. (US) 1997-02-25 US disclosed
WO-1995016692-A1 HETEROCYCLIC-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO., INC. (US) 1995-06-22 WO disclosed